The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
What Is The Expected Market Value Outlook For The Radiotherapy Market Through 2030?
The radiotherapy market size has demonstrated robust growth over recent years. It is anticipated to increase from $7.89 billion in 2025 to $8.44 billion in 2026, achieving a compound annual growth rate (CAGR) of 6.9%. The historical expansion can be ascribed to several factors, including the development of hospital radiotherapy infrastructure, the escalating global prevalence of cancer, the incorporation of linear accelerator technologies, advancements in diagnostic imaging, and the improved availability of trained radiation oncologists.
The radiotherapy market size is projected to experience robust expansion in the coming years. This market is anticipated to reach $10.93 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 6.7%. This expansion during the projection period is driven by several factors, including heightened investments in proton therapy facilities, a growing emphasis on personalized radiation dosages, the proliferation of outpatient radiotherapy centers, the increasing incorporation of AI-based planning systems, and a rising need for highly precise cancer treatments. Key trends expected during the forecast timeframe encompass the wider embrace of advanced external beam techniques, an increasing application of image-guided and adaptive radiotherapy, surging demand for proton and particle therapy, the broadening of multimodal cancer treatment methodologies, and an intensified concentration on the precision of treatment planning.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21267&type=smp
Which Drivers Are Advancing The Radiotherapy Market Growth?
The rising incidence of cancer is anticipated to propel the expansion of the radiotherapy market moving forward. Cancer is defined as a condition marked by the unchecked proliferation of anomalous cells, which can infiltrate and disseminate to diverse bodily regions, originating in various tissues and organs and resulting in a wide array of types and symptoms. The growing frequency of cancer cases can be attributed to factors such as an aging demographic, shifts in lifestyle like inadequate nutrition and inactive routines, elevated rates of tobacco and alcohol consumption, environmental contamination, and enhanced diagnostic tools leading to more detections. Radiotherapy plays a vital role in the management of cancer by precisely targeting and eradicating malignant cells, thereby aiding in tumor volume reduction and enhancing patient prognosis. As an illustration, in August 2024, Macmillan Cancer Support, a UK-based charitable organization dedicated to assisting cancer patients, reported that over 3 million individuals in the UK are living with cancer in 2024, with this figure projected to climb to 3.5 million by 2025, 4 million by 2030, and 5.3 million by 2040. Consequently, the increasing prevalence of cancer is a key driver for the growth of the radiotherapy market.
How Is Segment Classification Applied In The Radiotherapy Market?
The radiotherapy market covered in this report is segmented –
1) By Therapy Type: External Beam Radiation Therapy, Internal Beam Radiation Therapy, Systemic Radiation Therapy
2) By Application: Prostate Cancer, Breast Cancer, Lung Cancer, Head And Neck Cancer, Colorectal Cancer, Gynecological Cancer, Cervical Cancer, Penile Cancer, Other Applications
3) By End-User: Hospitals And Diagnostic Laboratories, Cancer Treatment And Research Centers, Academic Research Organizations, Ambulatory Surgery Centers, Other End-Users
Subsegments:
1) By External Beam Radiation Therapy: Intensity-Modulated Radiation Therapy (IMRT), Stereotactic Body Radiation Therapy (SBRT), 3D Conformal Radiation Therapy (3D-CRT), Proton Beam Therapy, Image-Guided Radiation Therapy (IGRT), Volumetric Modulated Arc Therapy (VMAT)
2) By Internal Beam Radiation Therapy: Brachytherapy (High-Dose Rate), Brachytherapy (Low-Dose Rate), Intraoperative Radiation Therapy (IORT), Permanent Seed Implants
3) By Systemic Radiation Therapy: Radioisotope Therapy, Targeted Radionuclide Therapy, Radioimmunotherapy, Peptide Receptor Radionuclide Therapy (PRRT)
What Trends Are Influencing The Radiotherapy Market Outlook?
Key players within the radiotheranostics market are concentrating on developing innovative offerings to enhance the production and availability of therapeutic radioisotopes, improve the precision of treatments, and address the growing demand for targeted cancer therapies. For example, in May 2023, Advanced Cyclotron Systems Inc., a company based in Canada that provides and maintains cyclotrons predominantly used for producing medical isotopes, launched TR-ALPHA, a specialized cyclotron for manufacturing alpha-emitting radioisotopes to treat cancer. Designed to meet the market’s need for a cost-effective cyclotron capable of producing large quantities of Astatine-211, which is one of the most promising alpha-emitting radioisotopes, the TR-ALPHA is smaller, more affordable, and easier to operate than previous models, making it an ideal solution for hospitals, research institutions, and organizations aiming to efficiently produce therapeutic alpha-emitting radioisotopes.
Which Key Players Are Active In The Radiotherapy Market?
Major companies operating in the radiotherapy market are Hitachi Ltd., GE Healthcare Technologies Inc., Sumitomo Heavy Industries Ltd., Varian Medical Systems Inc., Elekta AB, Accuray Incorporated, Ion Beam Applications S.A, Canon Medical Systems Corporation, RefleXion Medical Inc., Mevion Medical Systems Inc., Nordion Inc., Theragenics Corporation, RaySearch Laboratories AB, MIM Software Inc., Vision RT Ltd., Sun Nuclear Corporation, Provision Healthcare LLC, Panacea Medical Technologies Pvt. Ltd., Optivus Proton Therapy Inc., Perspective Therapeutics Inc., GT Medical Technologies Inc., ProTom International Inc.
Access The Complete Radiotherapy Market Report:
https://www.thebusinessresearchcompany.com/report/radiotherapy-global-market-report
Which Geographic Region Represents The Largest Radiotherapy Market Share?
North America was the largest region in the radiotherapy market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the radiotherapy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access Radiotherapy Market Report for Deeper Competitive Insights
https://www.thebusinessresearchcompany.com/customise?id=21267&type=smp
Browse Through More Reports Similar to the Global Radiotherapy Market 2026, By The Business Research Company
Diagnostic Radioisotopes Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/diagnostic-radioisotopes-global-market-report
Radome Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/radome-global-market-report
Oncologists Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/oncologists-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model









